Clinical Trials
3 trialsNCT03581487 2025-11-05
Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03326388 2024-04-04
INSPECT
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2 Completed
NCT02025114 2018-07-10
Selumetinib in Combination With Gefitinib in NSCLC Patients
National Taiwan University Hospital
Phase 1/2 Completed